135 related articles for article (PubMed ID: 15543611)
1. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.
Pedrero JM; Carracedo DG; Pinto CM; Zapatero AH; Rodrigo JP; Nieto CS; Gonzalez MV
Int J Cancer; 2005 Mar; 114(2):242-8. PubMed ID: 15543611
[TBL] [Abstract][Full Text] [Related]
2. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
Cantley LC; Neel BG
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4240-5. PubMed ID: 10200246
[TBL] [Abstract][Full Text] [Related]
3. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway.
Seo JH; Ahn Y; Lee SR; Yeol Yeo C; Chung Hur K
Mol Biol Cell; 2005 Jan; 16(1):348-57. PubMed ID: 15537704
[TBL] [Abstract][Full Text] [Related]
4. Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis.
Stiles B; Gilman V; Khanzenzon N; Lesche R; Li A; Qiao R; Liu X; Wu H
Mol Cell Biol; 2002 Jun; 22(11):3842-51. PubMed ID: 11997518
[TBL] [Abstract][Full Text] [Related]
5. PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells.
Lee C; Kim JS; Waldman T
Cancer Res; 2004 Oct; 64(19):6906-14. PubMed ID: 15466180
[TBL] [Abstract][Full Text] [Related]
6. Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.
Alvi AJ; Hogg R; Rader JS; Kuo MJ; Maher ER; Latif F
Mol Pathol; 2002 Jun; 55(3):153-5. PubMed ID: 12032225
[TBL] [Abstract][Full Text] [Related]
7. PPARG and the PTEN-PI3K/AKT Signaling Axis May Cofunction in Promoting Chemosensitivity in Hypopharyngeal Squamous Cell Carcinoma.
Han B; Chen J; Chen S; Shen X; Hou L; Fang J; Lian M
PPAR Res; 2024; 2024():2271214. PubMed ID: 38505269
[TBL] [Abstract][Full Text] [Related]
8. Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues.
Wu WH; Li FY; Shu YC; Lai JM; Chang PM; Huang CF; Wang FS
R Soc Open Sci; 2020 Mar; 7(3):191241. PubMed ID: 32269785
[TBL] [Abstract][Full Text] [Related]
9. mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.
Wang Z; Martin D; Molinolo AA; Patel V; Iglesias-Bartolome R; Degese MS; Vitale-Cross L; Chen Q; Gutkind JS
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25099740
[TBL] [Abstract][Full Text] [Related]
10. Retraction.
Int J Cancer; 2019 Sep; 145(5):1453. PubMed ID: 31283014
[No Abstract] [Full Text] [Related]
11. Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma.
Levi L; Hikri E; Popovtzer A; Dayan A; Levi A; Bachar G; Mizrachi A; Shoffel-Havakuk H
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835812
[TBL] [Abstract][Full Text] [Related]
12. Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer.
Mathebela P; Damane BP; Mulaudzi TV; Mkhize-Khwitshana ZL; Gaudji GR; Dlamini Z
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430229
[TBL] [Abstract][Full Text] [Related]
13. Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy.
Bouyahya A; El Allam A; Aboulaghras S; Bakrim S; El Menyiy N; Alshahrani MM; Al Awadh AA; Benali T; Lee LH; El Omari N; Goh KW; Ming LC; Mubarak MS
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428613
[TBL] [Abstract][Full Text] [Related]
14. The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An
Zaryouh H; De Pauw I; Baysal H; Pauwels P; Peeters M; Vermorken JB; Lardon F; Wouters A
Front Oncol; 2021; 11():697967. PubMed ID: 34568028
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Targeting Tumor Cells and Cancer-Associated Fibroblasts with a Paclitaxel-Hyaluronan Bioconjugate: In Vitro Evaluation in Non-Melanoma Skin Cancer.
Bellei B; Caputo S; Migliano E; Lopez G; Marcaccini V; Cota C; Picardo M
Biomedicines; 2021 May; 9(6):. PubMed ID: 34073987
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Significance of FOXO4 Expression and Correlation with Prx1 in Head and Neck Squamous Cell Carcinoma.
Lu Y; Shen Y; Li L; Zhang M; Wang M; Ge L; Yang J; Tang X
Anal Cell Pathol (Amst); 2021; 2021():5510753. PubMed ID: 34055579
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the
Starzyńska A; Sejda A; Adamska P; Marvaso G; Sakowicz-Burkiewicz M; Adamski Ł; Jereczek-Fossa BA
Arch Med Sci; 2021; 17(1):207-217. PubMed ID: 33488873
[TBL] [Abstract][Full Text] [Related]
18.
García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH
Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00460 promotes head and neck squamous cell carcinoma cell progression by sponging miR-612 to up-regulate AKT2.
Xie X; Xiong G; Wang Q; Ge Y; Cui X
Am J Transl Res; 2019; 11(10):6326-6340. PubMed ID: 31737186
[TBL] [Abstract][Full Text] [Related]
20. The Specificity of EGF-Stimulated IQGAP1 Scaffold Towards the PI3K-Akt Pathway is Defined by the IQ3 motif.
Chen M; Choi S; Jung O; Wen T; Baum C; Thapa N; Lambert PF; Rapraeger AC; Anderson RA
Sci Rep; 2019 Jun; 9(1):9126. PubMed ID: 31235839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
